Allergy Therapeutics Stock Price, News & Analysis (LON:AGY)

GBX 28.13 -0.02 (-0.07 %)
(As of 12/14/2017 04:00 PM ET)
Previous CloseGBX 28.13
Today's RangeGBX 28 - GBX 28.15
52-Week RangeGBX 19.71 - GBX 39.50
Volume28,472 shs
Average Volume90,755 shs
Market Capitalization£191.99 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Allergy Therapeutics (LON:AGY)

Allergy Therapeutics logoAllergy Therapeutics Plc is a pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum-free products. The Company's segments are Central Europe, which includes segments, such as Germany, Australia, Switzerland and the Netherlands; Southern Europe, which includes Italy and Spain; the United Kingdom, and Rest of World. The Company provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's products include Pollinex Trees, Pollinex Grasses+Rye, Skin Prick Testing and diagnostic products. Its vaccines trade under various brand names, such as Pollinex Quattro, Polligoid and TA Graser Top. It uses specialized systems to process the Tyrosine to form a suspension microcrystalline tyrosine (MCT) that is combined with some of its subcutaneous injected therapies.

Receive AGY News and Ratings via Email

Sign-up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryN/A
SectorPharmaceuticals - NEC
SymbolLON:AGY
CUSIPN/A
Phone+44-1903-844700

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net Margins-39.32%
Return on Equity-54.34%
Return on Assets-30.47%

Miscellaneous

EmployeesN/A
Outstanding Shares603,970,000

Allergy Therapeutics (LON:AGY) Frequently Asked Questions

What is Allergy Therapeutics' stock symbol?

Allergy Therapeutics trades on the London Stock Exchange (LON) under the ticker symbol "AGY."

Where is Allergy Therapeutics' stock going? Where will Allergy Therapeutics' stock price be in 2017?

4 equities research analysts have issued 1 year price targets for Allergy Therapeutics' stock. Their forecasts range from GBX 45 to GBX 60. On average, they anticipate Allergy Therapeutics' stock price to reach GBX 51.25 in the next twelve months. View Analyst Ratings for Allergy Therapeutics.

Who are some of Allergy Therapeutics' key competitors?

Who are Allergy Therapeutics' key executives?

Allergy Therapeutics' management team includes the folowing people:

  • Manuel Llobet, Chief Executive Officer, Executive Director (Age 50)
  • Nicolas Alexander Ulrich Wykeman, Finance Director (Age 51)
  • Peter Sinclair Jensen, Non-Executive Chairman of the Board (Age 63)
  • Jeff Barton, Non-Executive Director
  • Tunde Otulana, Non-Executive Independent Director (Age 60)
  • Stephen Rushworth Smith, Senior Non-Executive Independent Director (Age 61)

How do I buy Allergy Therapeutics stock?

Shares of Allergy Therapeutics and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Allergy Therapeutics' stock price today?

One share of Allergy Therapeutics stock can currently be purchased for approximately GBX 28.13.

How big of a company is Allergy Therapeutics?

Allergy Therapeutics has a market capitalization of £191.99 million.

How can I contact Allergy Therapeutics?

Allergy Therapeutics' mailing address is Dominion Way, WORTHING, BN14 8SA, United Kingdom. The company can be reached via phone at +44-1903-844700.


MarketBeat Community Rating for Allergy Therapeutics (AGY)

Community Ranking:  3.9 out of 5 (star star star)
Outperform Votes:  225 (Vote Outperform)
Underperform Votes:  64 (Vote Underperform)
Total Votes:  289
MarketBeat's community ratings are surveys of what our community members think about Allergy Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Allergy Therapeutics (LON:AGY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 51.25GBX 51.25GBX 51GBX 50.25

Allergy Therapeutics (LON:AGY) Consensus Price Target History

Price Target History for Allergy Therapeutics (LON:AGY)

Allergy Therapeutics (LON:AGY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
12/5/2017Numis SecuritiesReiterated RatingBuyGBX 45View Rating Details
11/21/2017FinnCapReiterated RatingBuyGBX 47View Rating Details
9/28/2017Panmure GordonReiterated RatingBuyView Rating Details
4/4/2017Stifel NicolausReiterated RatingBuyGBX 60View Rating Details
(Data available from 12/14/2015 forward)

Earnings

Earnings History for Allergy Therapeutics (LON:AGY)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Allergy Therapeutics (LON:AGY) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Allergy Therapeutics (LON:AGY)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Allergy Therapeutics (LON AGY) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Allergy Therapeutics (LON:AGY)

Allergy Therapeutics (LON AGY) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/11/2017Tunde OtulanaInsiderBuy25,000GBX 51£12,750
9/29/2016Peter JensenInsiderBuy30,000GBX 19£5,700
9/27/2016Nicolas WykemanInsiderBuy150,000GBX 18£27,000
7/27/2015Llobet ,ManuelInsiderBuy50,000GBX 24£12,000
(Data available from 1/1/2013 forward)

Headlines

Allergy Therapeutics (LON AGY) News Headlines

Source:
DateHeadline
Allergy Therapeutics (AGY) Buy Rating Reiterated at Numis SecuritiesAllergy Therapeutics' (AGY) Buy Rating Reiterated at Numis Securities
www.americanbankingnews.com - December 10 at 8:06 PM
Allergy Therapeutics to Present at Jefferies 2017 - London South East (blog)Allergy Therapeutics to Present at Jefferies 2017 - London South East (blog)
www.lse.co.uk - November 14 at 4:23 AM
Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : November 10, 2017Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : November 10, 2017
finance.yahoo.com - November 10 at 2:37 PM
Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: For the six months ended June 30, 2017 : November 2, 2017Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: For the six months ended June 30, 2017 : November 2, 2017
finance.yahoo.com - November 2 at 9:02 PM
Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: 2017 By the Numbers : October 24, 2017Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: 2017 By the Numbers : October 24, 2017
finance.yahoo.com - October 24 at 9:35 PM
Allergy Thera. Share ChatAllergy Thera. Share Chat
www.lse.co.uk - October 24 at 2:48 AM
Allergy Therapeutics plc (AGY) Rating Reiterated by FinnCapAllergy Therapeutics plc (AGY) Rating Reiterated by FinnCap
www.americanbankingnews.com - October 21 at 9:58 PM
Allergy Therapeutics plc (AGY) Insider Acquires £12,750 in StockAllergy Therapeutics plc (AGY) Insider Acquires £12,750 in Stock
www.americanbankingnews.com - October 12 at 1:22 PM
Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : November 24, 2016Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : November 24, 2016
finance.yahoo.com - October 5 at 12:59 PM
Allergy Therapeutics Plc breached its 50 day moving average in a Bullish Manner : AGY-GB : January 9, 2017Allergy Therapeutics Plc breached its 50 day moving average in a Bullish Manner : AGY-GB : January 9, 2017
finance.yahoo.com - October 5 at 12:59 PM
Allergy Therapeutics Plc – Value Analysis (LONDON:AGY) : January 10, 2017Allergy Therapeutics Plc – Value Analysis (LONDON:AGY) : January 10, 2017
finance.yahoo.com - October 5 at 12:59 PM
Allergy Therapeutics: Positive Efficacy and Safety Data Shown in Peanut Allergy VaccineAllergy Therapeutics: Positive Efficacy and Safety Data Shown in Peanut Allergy Vaccine
finance.yahoo.com - October 5 at 12:59 PM
Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : March 23, 2017Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : March 23, 2017
finance.yahoo.com - October 5 at 12:59 PM
Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : May 5, 2017Allergy Therapeutics Plc breached its 50 day moving average in a Bearish Manner : AGY-GB : May 5, 2017
finance.yahoo.com - October 5 at 12:58 PM
Allergy Therapeutics Plc – Value Analysis (LONDON:AGY) : May 8, 2017Allergy Therapeutics Plc – Value Analysis (LONDON:AGY) : May 8, 2017
finance.yahoo.com - October 5 at 12:58 PM
Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: For the six months ended December 31, 2016 : May 12, 2017Allergy Therapeutics Plc :AGY-GB: Earnings Analysis: For the six months ended December 31, 2016 : May 12, 2017
finance.yahoo.com - October 5 at 12:58 PM
Allergy Therapeutics Plc breached its 50 day moving average in a Bullish Manner : AGY-GB : May 18, 2017Allergy Therapeutics Plc breached its 50 day moving average in a Bullish Manner : AGY-GB : May 18, 2017
finance.yahoo.com - October 5 at 12:58 PM
FinnCap Increases Allergy Therapeutics plc (AGY) Price Target to GBX 47FinnCap Increases Allergy Therapeutics plc (AGY) Price Target to GBX 47
www.americanbankingnews.com - September 30 at 4:08 PM
Allergy Therapeutics plc (AGY) Stock Rating Reaffirmed by Numis Securities LtdAllergy Therapeutics plc (AGY) Stock Rating Reaffirmed by Numis Securities Ltd
www.americanbankingnews.com - September 30 at 3:28 PM
Allergy Therapeutics plc (AGY) Given Buy Rating at Panmure GordonAllergy Therapeutics plc (AGY) Given Buy Rating at Panmure Gordon
www.americanbankingnews.com - September 30 at 2:54 PM
Allergy Therapeutics: Preliminary ResultsAllergy Therapeutics: Preliminary Results
globenewswire.com - September 28 at 4:15 PM
Allergy Therapeutics plc (AGY) Rating Reiterated by Numis Securities LtdAllergy Therapeutics plc (AGY) Rating Reiterated by Numis Securities Ltd
www.americanbankingnews.com - September 22 at 9:02 PM
Allergy Therapeutics plc (AGY) Stock Rating Reaffirmed by FinnCapAllergy Therapeutics plc (AGY) Stock Rating Reaffirmed by FinnCap
www.americanbankingnews.com - August 28 at 5:02 PM
Half Year 2017 Allergy Therapeutics PLC Earnings Release - Before Market OpenHalf Year 2017 Allergy Therapeutics PLC Earnings Release - Before Market Open
biz.yahoo.com - March 9 at 3:28 PM
DGAP-News: Bencard Allergie GmbH: Update zur ... - FinanzNachrichten.deDGAP-News: Bencard Allergie GmbH: Update zur ... - FinanzNachrichten.de
www.finanznachrichten.de - January 19 at 3:42 PM
Secretive Biotech Unicorn Moderna Unveils Pipeline, Financials - BloombergSecretive Biotech Unicorn Moderna Unveils Pipeline, Financials - Bloomberg
www.bloomberg.com - January 10 at 1:41 AM
Ultragenyx and Kyowa Kirin International Announce Marketing Authorization Application for KRN23 Filed and Accepted ... - GlobeNewswire (press release)Ultragenyx and Kyowa Kirin International Announce Marketing Authorization Application for KRN23 Filed and Accepted ... - GlobeNewswire (press release)
globenewswire.com - January 5 at 8:32 PM
Do today’s results make this company a better buy than Shire plc?Do today’s results make this company a better buy than Shire plc?
uk.finance.yahoo.com - September 26 at 9:32 AM
Full Year 2016 Allergy Therapeutics PLC Earnings Release - Before Market OpenFull Year 2016 Allergy Therapeutics PLC Earnings Release - Before Market Open
biz.yahoo.com - September 26 at 9:32 AM

SEC Filings

Allergy Therapeutics (LON:AGY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Allergy Therapeutics (LON AGY) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.